Halaman 5 - Hematologi Onkologi hematolog-onkologis Terbaik - TOP-171 dokter

Pelopor dalam penggunaan interferon untuk MPN sejak 1980-an, Prof. Gisslinger adalah ahli hematologi terkemuka di Medical University of Vienna.

• 20+ tahun mengembangkan pengobatan untuk neoplasma mieloproliferatif
• Pendiri Laboratorium Neoplasma Mieloproliferatif
• Spesialisasi dalam polisitemia vera, trombositemia esensial, dan mielofibrosis
• Direktur Program untuk penelitian Neoplasma Mieloproliferatif

Spesialis radioterapi untuk onkologi, yang berfokus pada perawatan pasien kanker dengan radiasi di Rambam Medical Center.

• Spesialisasi dalam penggunaan radioterapi untuk mengobati kanker, termasuk limfoma dan leukemia
• Menggabungkan keahlian dalam radiasi dan onkologi medis untuk perawatan pasien
• Berfokus pada rencana perawatan yang dipersonalisasi untuk limfoma Hodgkin
• Menggunakan teknik radioterapi canggih untuk perawatan kanker yang presisi

Profesor Dina Ben-Yehuda memelopori terapi gen dan transplantasi sumsum tulang di Hadassah Medical Center – departemen hematologi terkemuka di Israel.

• Kepala Hematologi dengan pengalaman 30+ tahun
• Menempuh pendidikan di Memorial Sloan-Kettering Cancer Center di New York
• Dekan wanita pertama di Fakultas Kedokteran Hadassah
• Penerima Penghargaan Healing with the Heart untuk perawatan pasien yang luar biasa
• Spesialisasi dalam diagnostik molekuler untuk kanker darah

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Diakui oleh Forbes sebagai salah satu dokter terbaik pada tahun 2018 – Dr. Stepensky telah melakukan lebih dari 3.500 transplantasi sumsum tulang di Hadassah Medical Center.

• Spesialisasi lebih dari 20 tahun dalam transplantasi sumsum tulang pediatrik
• Fokus pada penyakit kanker darah langka pada anak-anak
• Dikenal di kalangan pasien sebagai 'orang yang mentransplantasikan kehidupan'
• Memimpin unit hematologi pediatrik yang berdedikasi

80+ uji klinis aktif pada CLL – Prof. Bosch memimpin penelitian terobosan di Rumah Sakit Quiron Barcelona untuk memajukan pengobatan limfoma di seluruh dunia.

• Pemimpin terkenal di dunia dalam Leukemia Limfositik Kronis dan limfoma
• Kepala Hematologi di Rumah Sakit Universitas Vall d'Hebron dan IOB Institute of Oncology
• Menerbitkan lebih dari 100 studi di jurnal ternama seperti NEJM dan Nature Medicine
• Presiden kelompok riset CLL Spanyol (GELLC)
• Menempuh pendidikan di Institute of Cancer Genetics, Columbia University

Dr. Irina Zaidman spesialis dalam transplantasi sumsum tulang anak, menempuh pendidikan di institusi ternama di seluruh dunia termasuk Hospital for Sick Children di Toronto.

• Anggota dewan Masyarakat Hemato-Onkologi Anak Israel
• Aktif dalam pengajaran dan penelitian tentang transplantasi pediatrik
• Anggota perkumpulan BMT Eropa dan Amerika
• Mempublikasikan berbagai artikel tentang transplantasi sumsum tulang anak

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Ofer Spielberg adalah seorang onkohematologi di Assuta Medical Center, yang berspesialisasi dalam kanker darah seperti limfoma dan leukemia.

• Berfokus secara eksklusif pada keganasan hematologi dan gangguan darah yang kompleks
• Ahli dalam transplantasi sumsum tulang dan protokol pengobatan modern
• Memberikan perawatan yang dipersonalisasi di rumah sakit swasta terkemuka di Israel

Dr. Li Ping, M.D., Ph.D., is Chief Physician and Professor in the Department of Hematology at Shanghai Tongji Hospital, Tongji University School of Medicine. She supervises doctoral and master's students and is an expert in hematologic malignancies.

She earned a Doctor of Medical Science from Nagoya University and completed postdoctoral research. She specializes in diagnosing and treating blood cancers. Her focus includes lymphoid malignancies—leukemias, lymphomas, and multiple myeloma. She treats patients with chemotherapy, hematopoietic stem cell transplantation, targeted therapy, and immunotherapy.

She is a pioneer in China in full-cycle CAR-T therapy for relapsed or refractory blood cancers. She leads and participates in national and international clinical trials. She serves on committees of professional societies, including the China Anti-Cancer Association. She also publishes and trains hematologists.

Dr. Ozden Gul berspesialisasi dalam onkologi bedah dengan keahlian dalam teknik minimal invasif, memastikan pemulihan yang lebih cepat dan jaringan parut minimal bagi pasien.

• Menempuh pendidikan di Universitas Istanbul Cerrahpaşa – salah satu sekolah kedokteran terkemuka di Turki
• Berspesialisasi dalam bedah gastrointestinal, endokrin, dan kanker payudara
• Fasih berbahasa Inggris, memfasilitasi komunikasi yang jelas dengan pasien internasional
• Bekerja di rumah sakit terkemuka termasuk Rumah Sakit Pelatihan dan Penelitian Haydarpaşa Numune

Kepala program transplantasi sumsum tulang terbesar di Italia – Dr. Peccatori mengawasi 90+ transplantasi alogenik setiap tahun di San Raffaele.

• 20+ tahun memimpin Unit Transplantasi Sumsum Tulang
• Menerbitkan 70+ studi tentang transplantasi dan kanker hematologi
• Spesialisasi dalam limfoma dan kasus transplantasi yang kompleks
• Anggota European Society for Blood and Marrow Transplantation